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In all patients, closure of the puncture site took place in the interventional radiology room immediately after the procedure. The guidewire provided with the Angioseal set was passed through the arterial sheath. Manual pressure was applied at the puncture site and the sheath was carefully removed over the wire. The 6F Angioseal sheath was then passed over the wire and placed into the artery. The anchor was set in position by deploying the device through the sheath. The anchor was then pulled back gently and the puncture sealed by pulling the self tightening string. The string was then cut short to the skin.
Results
There were a total of 6 complications (4.47%), of which 1 was a major complication (0.75%) -retroperitoneal bleed. There were 5 minor complications (3.73%), which included device deployment failure (2), device malfunction (2) and a superficial haematoma (>6cm). Total complications were 6 out of 157 (3.8%) (95% CI {0.8%-6.8%}). Successful haemostasis was achieved in under 5minutes in over 97% of patients. Successful device deployment was seen in over 98% of casesTable 1 on page 5 . Table 1 Conclusion
We conclude that in our experience, the Angioseal vascular closure device is a safe and efficient means of achieving haemostasis post antegrade/retrograde puncture for diagnostic and percutaneous intervention procedures.
